Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Trading Update

8 Feb 2019 07:00

RNS Number : 4379P
GLI Finance Limited
08 February 2019
 

8 February 2019

 GLI Finance Limited("the Group")

Trading Update

GLI Finance today announces a trading update.

Sancus BMS

The Group's core business, Sancus BMS Group Limited ("Sancus BMS"), continues to grow, with revenue for the year ended 31 December 2018 ("FY18") expected to be approximately £13 million, representing a 28% increase over the prior year. The Group also generated record loan origination levels in FY18 (approximately £168 million of funding, representing a 21% increase over the prior year). 

Sancus Finance Limited ("Sancus Finance"), a subsidiary of the Group which operates its supply chain finance offering in the UK, remains loss making and while its performance improved in 2018, it is behind management's expectations with a forecast operating loss of £1 million. The Group believes the market for supply chain finance has changed significantly, with credit insurers reducing appetite to write cover and increasing premiums markedly. In light of this, and recognising the difficult market conditions facing supply chain finance more generally, the Group has taken the decision to close its supply chain finance offering. The Group also has a £1.1 million exposure to a supply chain finance borrower which recently went into administration and the Group will prudently recognise a provision in respect of its full exposure in FY18.

Sancus BMS's remaining operations in the UK will continue to provide education funding and asset backed lending. More broadly, the Group remains focussed on the core asset backed lending offering in the 6 jurisdictions in which it operates. Sancus BMS recently surpassed a £1 billion total lending milestone and, with a very strong pipeline and a proprietary electronic platform, the business is well placed to achieve further scale.

Fintech Ventures

The Group also announces that it expects to suffer further material write downs in its Fintech Ventures portfolio. It has recently become apparent that several of the platforms are finding it harder to raise further capital at the valuation levels previously expected. Those that successfully raised further capital in 2018 are better placed to execute on their long-term business plans but this has, in some cases, resulted in a significant dilution for GLI.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014.

GLI Finance

+44 (0)1534 708900

Andy Whelan

 

 

 

Nominated Adviser and Broker

 

Liberum Capital Limited

+44 (0)203 100 2000

Chris ClarkeSteve Pearce

 

Trystan Cullen

 

 

 

Public Relations Adviser

 

Instinctif Partners

+44 (0)207 457 2020

Tim Linacre

 

Katie Bairsto

 

 

 

LEI: 213800S2XOO3YSEGCA26

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSSMEEWFUSEDE
Date   Source Headline
18th Sep 20137:00 amRNSAdditional Listing
2nd Sep 20137:00 amRNSInvestment in crowd-funding platform
16th Aug 20134:15 pmRNSHolding(s) in Company
25th Jul 20137:58 amRNSNAV and Trading Update
25th Jul 20137:58 amRNSDividend Declaration
16th Jul 20137:00 amRNSInvestment
17th Jun 20137:00 amRNSDirector/PDMR Shareholding
14th Jun 20137:00 amRNSAdditional Listing
10th Jun 201311:00 amRNSShare Dealing
6th Jun 20134:00 pmRNSDirector/PDMR Shareholding
24th May 20135:00 pmRNSDirector/PDMR Shareholding
22nd May 20138:00 amRNSDirector/PDMR Shareholding
17th May 20139:00 amRNSDirector/PDMR Shareholding
15th May 20138:20 amRNSDirector/PDMR Shareholding
14th May 20134:30 pmRNSDirector/PDMR Shareholding
13th May 20138:00 amRNSHolding(s) in Company
30th Apr 20134:00 pmRNSResult of AGM
25th Apr 20138:30 amRNSHolding(s) in Company
23rd Apr 20134:45 pmRNSDirector/PDMR Shareholding
22nd Apr 20133:15 pmRNSHolding(s) in Company
18th Apr 20138:15 amRNSNAV Update and CLO Test Result
18th Apr 20138:15 amRNSDividend Declaration
9th Apr 20135:30 pmRNSAnnual Report
3rd Apr 20137:00 amRNSFull Year Results 2012
28th Mar 20137:02 amRNSNotice of Preliminary Results
23rd Jan 20137:01 amRNSPlacing
23rd Jan 20137:00 amRNSNAV Update, dividend payment and CLO Test Results
18th Jan 20132:49 pmRNSDirector/PDMR Shareholding
19th Nov 20122:30 pmRNSHolding(s) in Company
14th Nov 201212:00 pmRNSHolding(s) in Company
13th Nov 20128:00 amRNSHolding(s) in Company
12th Nov 201212:30 pmRNSDirector/PDMR Shareholding
8th Nov 201212:45 pmRNSConfirmation of Final Consideration Payable
7th Nov 20127:00 amRNSAcquisition
29th Oct 20127:00 amRNSAnnouncement of Dividend
19th Oct 20127:00 amRNSNAV Update and Quarterly CLO Test Results
20th Sep 20127:00 amRNSHalf Year Results 2012 Replacement
18th Sep 20126:27 pmRNSDirector/PDMR Shareholding
14th Sep 20127:00 amRNSHalf Year Results 2012
19th Jul 20129:00 amRNSTrading Statement
17th Jul 20123:51 pmRNSHolding(s) in Company
30th Apr 20125:00 pmRNSResult of AGM
20th Apr 20129:30 amRNSQuarterly CLO Test Results
19th Apr 20125:00 pmRNSNAV Update and dividend
5th Apr 20127:00 amRNSAnnual Financial Report
30th Mar 20122:46 pmRNSDealing by Investment Manager
26th Mar 20127:00 amRNSFull Year Results 2011
13th Mar 20127:00 amRNSNotice of Results
12th Mar 20127:00 amRNSChange of Adviser
19th Jan 20124:50 pmRNSNAV Update and Dividend Payment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.